Bert Vogelstein, MD, of Johns Hopkins University discovered new genetic pathways and processes contributing to cancer. Using cutting edge technologies and approaches, he identified new genetic defects that alter cell signaling, promote cell growth, and compromise the integrity of DNA repair. The work from his laboratory has advanced our understanding of cancer pathogenesis and led to the development of new diagnostic tests and targeted therapies for cancer.
